Efficacy News and Research

RSS
Infectex initiates enrollment in SQ109 Phase IIb-III trial for MDR-TB

Infectex initiates enrollment in SQ109 Phase IIb-III trial for MDR-TB

Clopidogrel pretreatment for PCI does not reduce risk of overall mortality

Clopidogrel pretreatment for PCI does not reduce risk of overall mortality

EMD Serono's L-BLP25 Phase III NSCLC trial does not meet primary endpoint

EMD Serono's L-BLP25 Phase III NSCLC trial does not meet primary endpoint

HAL Allergy completes enrollment in SUBLIVAC FIX Phleum pratense Phase II trial

HAL Allergy completes enrollment in SUBLIVAC FIX Phleum pratense Phase II trial

New once-daily dual bronchodilator effective in COPD

New once-daily dual bronchodilator effective in COPD

Pharmalink commences Nefecon Phase IIb study in primary IgA nephropathy

Pharmalink commences Nefecon Phase IIb study in primary IgA nephropathy

AHA/ASA identify top cardiovascular and stroke research advances for 2012

AHA/ASA identify top cardiovascular and stroke research advances for 2012

IRMA, Population Council and MTN release Rectal Revolution video project

IRMA, Population Council and MTN release Rectal Revolution video project

Maryland researchers launch groundbreaking study into spread of drug-resistant malaria in Burma

Maryland researchers launch groundbreaking study into spread of drug-resistant malaria in Burma

Abiraterone improves outcomes for prostate cancer prior to chemo

Abiraterone improves outcomes for prostate cancer prior to chemo

Lapatinib benefits found for HER2-positive early-stage patients

Lapatinib benefits found for HER2-positive early-stage patients

Lexicon receives FDA Fast Track status for development of LX1033 for irritable bowel syndrome

Lexicon receives FDA Fast Track status for development of LX1033 for irritable bowel syndrome

Allakos closes $32M Series A financing to develop antibody-based therapeutics

Allakos closes $32M Series A financing to develop antibody-based therapeutics

Naurex announces completion of $38M Series B financing

Naurex announces completion of $38M Series B financing

Low BMI a stronger risk factor for hip fracture among elderly men

Low BMI a stronger risk factor for hip fracture among elderly men

Efforts to prevent, treat cervical cancer increasing in Africa

Efforts to prevent, treat cervical cancer increasing in Africa

AcelRx announces top-line data from Sufentanil NanoTab PCA System Phase 3 trial

AcelRx announces top-line data from Sufentanil NanoTab PCA System Phase 3 trial

Ibrutinib continues to show unprecedented results in patients with mantle cell lymphoma

Ibrutinib continues to show unprecedented results in patients with mantle cell lymphoma

Cempra commences CEM-102 Phase 2 trial in prosthetic joint infections

Cempra commences CEM-102 Phase 2 trial in prosthetic joint infections

Altered gut microbiota associated with symptomatic atherosclerosis and stroke

Altered gut microbiota associated with symptomatic atherosclerosis and stroke

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.